GlaxoSmithKline Pharmaceuticals informs about issuance of duplicate share certificates

13 Dec 2023 Evaluate

Pursuant to Regulation 39 and other application regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the ‘Regulations’), GlaxoSmithKline Pharmaceuticals has informed that Registrar and Transfer Agent of Company - KFin Technologies has received request for issue of duplicate Share Certificates from Shareholder. The company will issue the Letter of Confirmation only after the necessary formalities are carried out by the Shareholder. Details of the shareholders and share certificate are enclosed.

The above information is a part of company’s filings submitted to BSE.




Glaxosmithkline Phar Share Price

2132.75 67.35 (3.26%)
26-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1504.25
Dr. Reddys Lab 6263.70
Cipla 1406.25
Zydus Lifesciences 948.20
Lupin 1615.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.